Cmed is a full service, technology-led CRO with a reputation for successfully delivering complex, demanding and innovative clinical trials. Cmed has conducted over 100 oncology studies across all phases and in numerous cancer types, including breast, lung, prostate, colorectal and other solid cancers, and also haematological cancers. This experience coupled with encapsia™, Cmed’s cloud based clinical data suite, supports better, faster decision making, real-time data capture using both eSource and EDC and the live, actionable review of data, enabling real reductions in time and cost.